Newsroom

Sorted by: Latest

-

Citibank UK Regulatory Announcement: Early Redemption(s)

LONDON--(BUSINESS WIRE)--  Please be advised that the following issue has redeemed early: ISIN: XS2950718770 Issuer: Silverstone Master Issuer Plc Call Date: 21/01/2026 Amount Redeeming: GBP 500,000,000 Call Price: 100%...
-

Refrigeration Equipment Global Market Report 2025-2030: Lucrative Opportunities in Sustainable Technologies, Natural Refrigerants, AI and IoT, & Cold Chain Infrastructure - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Refrigeration Equipment Market, Global, 2025-2030" report has been added to ResearchAndMarkets.com's offering. The revenue estimate for the base year 2024 is $67.06 billion with a CAGR of 8.7% for the study period 2024-2030. This report examines these shifts shaping the global refrigeration market. It analyzes the factors driving and restraining growth in this space and identifies the growth opportunities emerging from the changes for market players and stakeholder...
-

インサイト・ジャパン、再発・難治性濾胞性リンパ腫の治療を対象に、リツキシマブおよびレナリドミドとの併用療法として「ミンジュビ®(タファシタマブ)」の承認取得を発表

東京--(BUSINESS WIRE)--(ビジネスワイヤ) -- インサイト・バイオサイエンシズ・ジャパン合同会社(Incyte Biosciences Japan G.K.)は、再発・難治性濾胞性リンパ腫(FL)のうち、2次治療以降(2L+)の成人患者を対象とした、リツキシマブとレナリドミドとの併用療法である「ミンジュビ®(タファシタマブ)」について、厚生労働省(MHLW)より承認を取得したことを発表しました。 「リツキシマブおよびレナリドミドとの併用によるミンジュビの承認は、日本における再発・難治性FLを対象とした、CD19とCD20を同時に標的とする免疫療法併用として初の承認であり、重要な節目となります」と、インサイト・バイオサイエンシズ・ジャパンのジェネラルマネジャーである石田靖之は述べています。「無増悪生存期間の改善により、ミンジュビは、再発・難治性疾患の適格患者に対して、化学療法を用いない治療選択肢を提供します。今回の承認は、日本において、この困難な疾患の影響を受ける患者とそのご家族にとって重要な治療上のギャップを埋めるという、当社の取り組みを明確に示すものです。」 本...
-

ATIS Expands its Footprint in the Mid-Atlantic Through Acquisition of Bayline Lift Technologies

ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of Bayline Lift Technologies (Bayline) by ATIS, a TSCP portfolio company and premier provider of elevator and escalator safety inspections, consulting, and managed services across North America. Bayline provides elevator inspection services throughout the Mid-Atlantic. With the backing of ATIS’ team and resources, Bayline is poised for accelerated growth...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 22.12.2025 GMAY.LN IE000P0FL8E3 1,000,002.00 USD  38,316,053.72   38.316  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 22.12.2025 FTMO.LN IE000CY30YV9 3,050,002.00 USD  77,772,729.88   25.499  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 22.12.2025 SDVI.LN IE000YVOQ2A3   40,361.00 USD   1,078,488.44   26.721  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 22.12.2025 SDVY.LN IE0001R850E1 10,754,007.00 USD 252,319,415.31   23.463  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 22.12.2025 FTGS.LN IE000YZLMXT9   25,002.00 USD    560,795.85   22.430  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 22.12.2025 IPXE.IM IE00BFD26097 75,002.00 EUR 1,714,547.70 22.860  ...